Definitive surface markers for retinal progenitor cells (RPCs) are still lacking. Therefore, we sorted C-kit + and stage-specific embryonic antigen-4 (SSEA-4-) retinal cells for further biological characterization. RPCs were isolated from human fetal retinas (gestational age of 12 to 14 weeks). C-kit + /SSEA4 -RPCs were sorted by fluorescence-activated cell sorting, and their proliferation and differentiation capabilities were evaluated by immunocytochemistry and flow cytometry. The effectiveness and safety were assessed following injection of C-kit +
Introduction
Photoreceptor degeneration occurs as a result of disorders affecting either the photoreceptors themselves or the associated retinal pigment epithelium (RPE) cells. This disease is a common cause of blindness and severely affects a person's quality of life (Pinilla et al., 2004b) . Photoreceptor degeneration is difficult to treat because the pathological process involves the apoptosis of photoreceptors or retinal pigment epithelium cells, and photoreceptor cells cannot regenerate or self-repair. Although RPE cells have the capacity to proliferate in vivo and in vitro (Chiba, 2014; Stanzel et al., 2014) , it is difficult for damaged RPE cells to repair themselves (Chiba, 2014) . Currently, there are several treatment methods available, including gene therapy, transplantation therapy, drug therapy, and artificial vision prostheses. Rescuing or regenerating photoreceptor cells or RPE in patients with retinal degeneration is the key to treatment. Recently, stem cell-based cell therapy has become a hot topic. Schwartz reported the safety and tolerability of human embryonic stem cells(hESC)-derived RPE cells for the treatment of dry age-related macular degeneration (AMD) and Stargardt's disease; this report was the first description of the transplantation of hESC-derived cells into human patients (Schwartz et al., 2012) (Schwartz et al., 2015) .
Moreover, the authors observed no adverse proliferation or systemic safety issues related to the transplanted cells, and the best-corrected visual acuity was improved in some patients (Schwartz et al., 2012) (Schwartz et al., 2015) . Thus, this human ESC-based cell therapy in the blindness causing diseases is of highly significant for it provide the bright future for cell therapy in anydisease (Sowden, 2014) .
Tissue-specific retinal progenitor cells (RPCs) are an ideal source of differentiated cells
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with low tumour risk (Kajstura et al., 2011) . Currently, most RPCs used for transplantation are derived from ESCs or isolated from fetal tissues, but ESCs are difficult to differentiate in vitro, are not easily purified, and may contain a variety of cell types or cells at different development stages. The continuous development of flow cytometry to assess cell surface antigens has provided biomarkers that can be used to obtain highly purified tissue-specific RPCs. To date, several cell markers have proven to be suitable for the specific identification, isolation, and enrichment of RPCs (Carter et al., 2009; Koso et al., 2009 ); these markers are invaluable for RPC research.
Stem cell factor receptor C-kit (CD117), a progenitor cell marker, is a recognized antigen located on the cell surface that plays an important role in the survival, proliferation, and anti-apoptosis of haematopoietic stem cells (HSCs) and lung stem cells (Ellison et al., 2013) . Koso(Koso et al., 2007) identified C-kit as a RPC marker in the mouse retina, and demonstrated a dramatic change in the expression profiles of the cell surface antigens C-kit and stage-specific embryonic antigen (SSEA) on RPCs during development. Hasegawa demonstrated that the human embryonic retina has a pool of C-kit + cells; however, the authors did not further culture and characterize them (Hasegawa et al., 2008) . Stage-specific embryonic antigen-4 (SSEA-4), a human embryonic stem cell-associated antigen(Wright and Andrews, 2009), has previously been used as a marker to distinguish primitive embryonic stem cells (Kawanabe et al., 2012) . A sub-population of c-kit+ cells expressing SSEA-1 showed higher proliferative potential than c-kit + /SSEA1 -cells (Koso et al., 2007) . However, in contrast to mouse ESCs, human ESCs lack SSEA1 and express SSEA4 (Wright and Andrews, 2009 ). Therefore, to reduce the risk of tumourigenicity we used SSEA-4 as a surface marker
to exclude cells with high proliferative potential isolated from the retina of human fetuses using fluorescence-activated cell sorting.
We hypothesized that c-kit + cells isolated from fetal retina tissues represent a population of stem cells. The RPCs were evaluated for cell characteristics including self-renewal capacity, clonogenicity, the ability to differentiate into three types of retinal cells in vitro, and the ability to differentiate into photoreceptors in vivo. Additionally, we injected the cells into the subretinal space of Royal College of Surgeon (RCS) rats, an animal model in which vision deteriorates due to RPE dysfunction; these rats serve as a model for a recessive mutation in a receptor tyrosine kinase gene (Mertk) that results in the progressive death of the photoreceptors (Pinilla et al., 2004b) . Then, we observed the survival, migration, and differentiation of the cells, and determined their role in photoreceptor rescue and its impact on visual function. Finally, we assessed the safety of transplantation of C-kit+/SSEA-4-retinal progenitor cells into severe combined immune deficiency (SCID) mice. In our study, we found that the transplantation of C-kit+/SSEA4-cells derived from human fetal retina tissues could protect the neural retina and preserve the retinal outer nuclear layer in RCS rats.
Therefore, this study describes a method that may be used to obtain tissue-specific RPCs that could be used to delay the photoreceptor degeneartion and preserve the retinal outer nuclear layer in an animal model of retinal degeneration.
Results

Distribution of C-kit + cells in human fetal eyes
The fetal neural retina at 12-13 weeks mainly consists of two layers: the outer neuroblastic C-kit + cells were not only distributed in the retina, but also in the cornea and choroid of the eye from a 13-week-old human fetus. C-kit + cells were localized in the inner retina from the optic nerve to the ora serrata (Fig. S2) , although more cells were located in the peripheral portion than at the posterior pole of the retina; C-kit + cells were also scattered in the corneoscleral limbus of the cornea (Fig. S3 ) and choroid ( Fig. 1A-C ).
C-kit + /SSEA-4-cell isolation and culture
We found C-kit+ cells in the retinas of eyes from human fetuses. C-kit+/SSEA4-cells were sorted directly from the fetal retina; however, these cells were difficult to culture. Therefore, we first cultured retinal cells for 2-3 passages. Then, we collected retinal cells (a minimum of 5-10×10 6 cells) and sorted C-kit+/SSEA4-cells by FACS. These cells were collected and plated in 24-well plates (5×10 3 /cm 2 ) (Fig. 1G) . The morphology within the adherent population was spindle-shaped or displayed various other shapes (Fig. 1H ). In contrast, spheres were formed when the cells were grown in serum-free proliferation medium (Fig. 1J ).
The C-kit epitope remained detectable by immunofluorescence and FACS after passaging ( Fig.   1I ,K).
Characteristics of C-kit + /SSEA-4 -cells
Cells stained for RPC markers including Pax6, Sox2, Rax, and Nestin were analysed by flow cytometry and immunofluorescence. C-kit + /SSEA4 -cells were found to express Pax6 (91.6±
2.7%), Sox2 (95.2±2.0%), Rax (94.1±2.5%), and nestin (98.9±2.8%) (Fig. 3) . In contrast, they did not express the embryonic stem cell/tumour cell markers SSEA4 and the multi drug Journal of Cell Science Accepted manuscript resistance protein (MDR) (Fig. 2C, F ). Because C-kit + has also been described as a stem cell marker in other organs (i.e., mesenchymal stem cells (MSCs) and HSCs), we stained the sorted cells with MSC and HSC markers. The cells were negative for both the HSC markers (CD11b and CD45) (Fig. 2B, H ) and MSC markers (CD29 and CD140b) (Fig. 2E, I ).
Characterization of proliferation
The cells exhibited the ability to proliferate and grow in a monolayer on plastic plates in proliferation medium (Fig. 1H ) and form spheres in serum-free proliferation medium (Fig. 1J ).
Proliferating cells were identified by the proliferation marker ki67; the rate of ki67-positive expression was determined to be 82.0±3.1% by FACS, which is consistent with the immunofluorescence staining results (Fig. 4A, B ). Cells were seeded into 24 well-plates at a density of 10,000 cells/well, and the cell numbers were counted at 1,3,5,7, and 9 days after seeding (n = 3). Cell proliferation reached a maximum and then plateaued after the cells were plated; by 7 days, the cell number had increased by more than 20-fold ( Fig. 4D ). Additionally, we examined the cell cycle distribution of the C-kit cells, and found that 41.13 ± 2.99% cells were in the G2 and S phases (Fig. 4C ).
C-kit + cells were cultured under two different conditions: adherent conditions with proliferation medium and non-adherent conditions with serum-free medium. When a single C-kit + cell (sorted using flow cytometry) was seeded into a 96-well plate, clones formed approximately 20 days later (Fig. 1H ). The clones were digested, 500 cells were seeded into 10 cm dishes, and more colonies were formed. When these cells were cultured in serum-free medium, neurospheres formed after 20-30 days (Fig. 1J ). The spheres were defined as free-floating, with a diameter > 40 μm. The percentage of colony formation analysed after 30
Journal of Cell Science Accepted manuscript days was 0.06±0.01%，but the efficiency of colony formation was less than that observed under adherent conditions（3.33%±1.53%）(P <0.01). This finding is consistent with the results of a previous report (Rangel et al., 2013) .
Characterization of differentiation
Multipotency is another property of stem cells. Therefore, we used two differentiation media:
photoreceptor differentiation medium and glia differentiation medium. The in vitro differentiation was assessed by culturing C-kit + cells in differentiation medium for 3 weeks using the two types of differentiation media. Few differentiated cells expressed rhodopsin in the differentiation medium. In contrast, many cells differentiated into glial cells (66.7±5.8%).
Because previous studies have shown that retinoic acid can promote the differentiation of photoreceptor cells in vitro, we changed the medium for photoreceptor differentiation as previously described (Nakano et al., 2012; Li et al., 2013) .
Photoreceptor differentiation medium containing retinoic acid was used to culture C-kit + /SSEA4 -cells for 3 weeks. Then, we stained for photoreceptor cell markers (Otx2, Crx, rhodopsin, and recoverin), a ganglion cell marker (Thy1), and a glial cell marker (GFAP) ( Fig 
Differentiation of grafted cells
Our immunostaining results showed that some cells migrated into the inner retina 8 and 12
weeks after transplantion, and a small amount of cells expressed Recoverin (Fig. 6H)(Fig. S1 ).
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However, the majority of the cells were located in the subretinal space. 6M ).
Electroretinogram (ERG) measurement
ERG was performed and b-waves were measured at 4 weeks, 8 weeks, and 12 weeks.
Significantly high amplitude b-waves were detected in the transplanted group at 4 and 8 weeks compared to the control and untreated groups (P <0.01). Recordings at 12 weeks were not significantly different between the sham-surgery and untreated groups (P >0.05) ( Fig.   6N -Q).
Teratoma assay
The safety of C-kit + /SSEA4 -cells was tested by subcutaneous injection into the groin of six SCID mice; hESCs were injected into another six SCID mice as a positive control. After 8 weeks, no gross inflammatory reaction was observed in any of the animals, and teratomas
were not observed in the C-kit + /SSEA4 -cell group. In contrast, teratomas were seen in the Journal of Cell Science Accepted manuscript hESC group at 8 weeks post-injection (Fig. 7) .
Discussion
In 2011, the FDA approved phaseI/II clinical trials of cell transplantation therapy for AMD and Stargardt's disease, which led to immense advances in transplantation treatment of retinal degeneration (Schwartz et al., 2012) . RPC transplantation for the treatment of retinal degenerative diseases has become the most promising therapeutic strategy. C-kit + RPCs are derived from fetal retinas and have advantages including the potential to differentiate into retinal cells and low tumour risk. These factors make C-kit a good marker for the selection of candidate cells for transplantation to treat retinal degeneration.
Our results showed that cells expressing the C-kit epitope on their cell surface were distributed in the eye. C-kit + /SSEA4 -cells possessed characteristics of self-renewal and the ability to differentiate into three types of retinal cells. Due to the development of flow cytometry technology and the discovery of new cell surface antigens, researchers have been able to obtain higher purity stem cells by FACS. C-kit defines a regionally and temporally restricted immature subset of RPCs whose expression starts centrally and progresses centrifugally (Koso et al., 2007) .
At 9-10 fetal weeks, the retina was divided into outer neuroblastic layer (ONbL) and inner neuroblastic layer (INbL). At 11-13 fetal weeks, the ganglion cell layer(GCL) was several cell layers thick. A row of cones could be identified at the outer border of the outer neuroblastic layer(ONbL) adjacent to the RPE, and a thin IPL separated the OnbL from the differentiating GCL. The nerve fiber layer (NFL) was obvious on the inner border of the GCL close to the optic disc. Recoverin and cones marker s-opsin expressed at 11-12 weeks, and
Journal of Cell Science Accepted manuscript
rods markers expressed at 15-16 weeks (O'Brien et al., 2003; Hendrickson et al., 2008) . In our study, fetal neural retina at 12-13 weeks mainly consists of two layers: the outer neuroblastic layer (ONbL) and inner neuroblastic layer (INbL), which consist with fetal retinal development report (O'Brien et al., 2003; Hendrickson et al., 2008) . we found that C-kit + cells not only exist in the retina of the fetal eye, but are also located in the cornea and choroid; this finding was not reported by Hasegawa(Hasegawa et al., 2008) . Our results showed that C-kit cells were located in the inner layer of the retina; this finding is in agreement with the demonstration that the C-kit ligand SCF is also expressed in the inner retina (Hasegawa et al., 2008) . We successfully isolated and cultured C-kit + cells derived from the human fetal retina and identified their self-renewal, proliferation, and differentiation characteristics. We also successfully used surface markers to isolate tissue-specific RPCs that do not express SSEA-4.
It is important to obtain pure RPCs and to exclude other types of embryonic stem cells after isolation of eye tissue from the human fetus. The sorting of both the c-kit + and SSEA-4 -surface markers enabled us to obtain purified RPCs. Additionally, the sorted cells were stained with stem cell markers (MDR) by flow cytometry to ensure that there was no contamination with embryonic stem cells; a total of 99% of the double-marker sorted cells did not express the MDR marker.
C-kit + cells were previously reported to be able to survive under suspension or adherent growth conditions (Koso et al., 2007; Kajstura et al., 2011; Rangel et al., 2013) . The C-kit cells isolated in this study could also survive under both conditions. A higher proliferation rate was observed under adherent conditions (in media supplemented with FBS), which is consistent with Rangel's report. One possible reason for this finding is that the cell-cell
interactions and cell adhesion present in adherent conditions are important for ckit + cell growth (Rangel et al., 2013) . Retinal progenitor cells grown under adherent condition have also been reported to exhibit a greater proliferative potential than cells grown under suspension conditions (Xia et al., 2012) .
To ensure that the c-kit + /SSEA4 -cells sorted by FACS were highly tissue-specific, these cells were further evaluated for the human RPC tissue-specific markers nestin, Rax, Pax6, and Sox2 using immunohistochemistry and flow cytometry. More than 90% of the cells expressed the RPC markers Pax6, Sox2, Rax, and nestin, indicating that the cells were in an immature retinal cell state (Schmitt et al., 2009 ). Addditionally, cell proliferation potential was assesed using the ki67 marker. More than 80% of the C-kit + /SSEA4 -cells expressed this marker, demonstrating that the c-kit + /SSEA4 -cells possessed high proliferation ability in vitro and represented a highly pure and tissue-specific RPC with a certain proliferative capacity.
Furthermore, we found that C-kit + /SSEA4 -cells could form colonies under adherent and suspension conditions. This finding is consistent with the other properties of C-kit cells reported by Kajstura and Rangel(Kajstura et al., 2011; Rangel et al., 2013) .
In addition to proliferation capability, another characteristic of progenitor cells is differentiation capacity. In differentiation medium, c-kit + /SSEA4 -cells could be induced into photoreceptor cells, ganglion cells, and glial cells that expressed the corresponding cell-specific markers (Otx2, Crx, Recoverin, Rhodopsin, Thy1, and GFAP). However, in our study the proportion of cells expressing rhodopsin (4.0±0.3%) was lower than the proportion reported in Coles`s study (34.5±9.1%); furthermore, we found that more cells differentiated into glial cells (66.7±5.8%) than was previously reported (19.7±10.6%) (Coles, 2004) .
The transplantation of stem cells into the subretina of rats or mice retinal degeneration has been demonstrated to produce a neuroprotective effect (Tian et al., 2011; Tzameret et al., 2014) . In our study, we found that transplantation of C-kit + /SSEA4 -cells derived from human fetal retina tissue could protect neural retinas in RCS rats. The RCS rat is characterized by a recessive mutation in the Mertk gene, which is a receptor tyrosine kinase gene. This mutation precludes RPE cells from phagocytosing shed rod outer segments, leading to the progressive death of photoreceptor cells (Pinilla et al., 2004a) . Morphological changes are already evident by postnatal day (P)18 in pigmented RCS rats and include, among others, the disruption of outer segments (Davidorf et al., 1991) . Changes in photoreceptor nuclei are detected at P22 (Cuenca et al., 2005) , and the rod contribution to the mixed b-wave starts declining after P21 (Pinilla et al., 2004a) . We transplanted cells into the subretina at postnatal day 21, which is when photoreceptor degeneration begins (Luo et al., 2014) . Our experiment showed that Anai (Gonzalez-Cordero et al., 2013) noted that reliable electroretinographic responses were only achieved in mice following the rescue of 150,000 functioning rods. Our study showed that ONL thickness was maintained for at least 3 months after cell transplantation; however, the thickness decreased over time. This decrease is likely due to the fact that there
were not enough functional photoreceptors in the third month after transplantation. The grafted cells expressed the photoreceptor marker recoverin. However, the migrated human
RPCs failed to express the ganglion cell marker Thy1. It was previously reported (Luo et al., 2014) that stem cells grafted into the degenerative retina had difficulty differentiating into ganglion and photoreceptor cells in vivo; this finding was consistent with the results from our study.
Finally, the major concern regarding the use of progenitor cells for transplantation is tumourigenesis. The results from the teratoma assay showed that the transplantation of human RPCs was safe. There was no evidence of tumour formation 8 weeks after human RPC transplantation into the subretinal space of RCS rats.
In summary, our study demonstrated that C-kit + /SSEA4 -cells exist in human fetal eyes, and that these cells possess the stem cell properties of self-renewal, colony formation, and 
Materials and Methods
Cell isolation and culture
Eyes from human fetuses with a gestational age ranging from 12 to 14 weeks were obtained from spontaneous abortions at the Southwest Hospital, Third Military Medical University (Chongqing, China). The Ethics Committee of Southwest Hospital specifically approved this study, and it is registered in the Chinese Clinical Trial Register (ChiCTR; Registration number:
ChiCTR-TNRC-08000193). The gestational age of each fetus was determined using the last menstruation date and fetal foot length (Merz et al., 2000; Drey et al., 2005) . Postmortem
Journal of Cell Science Accepted manuscript times less than 1 hour were used because they do not alter the ability of progenitor cells in culture (Carter et al., 2007) .
Cells were isolated from the neuroretinas of human fetal eyes as previously described (Coles, 2004; Klassen et al., 2004; Aftab et al., 2009; Schmitt et al., 2009; Baranov et al., 2013) . Briefly, the eyes were rinsed in cold Hank's buffered salt solution (HBSS) (Hyclone, South Logan, Utah, USA). The neuroretina was dissociated into small pieces and enzymatically digested with 1 ml of papain (12 The proliferation medium included Dulbecco's Modified Eagle Medium:Nutrient Mixture F-12 (DMEM/F-12) (Hyclone) and supplemented with 20 ng/ml fibroblast growth factor-basic (bFGF, PeproTech, Rocky Hill, NewJersey, USA), 20 ng/ml epidermal growth factor (EGF, PeproTech), 1×insulin, transferrin, and selenium (ITS, GIBCO), 1×penicillin-streptomycin (P-S, GIBCO, Carlsbad, California,USA), and 10% FBS (GIBCO).
Immunocytochemistry
Immunocytochemistry was performed as previously described (Tian et al., 2011; Pearson et al., 2012) . Briefly, rats were euthanatized with an overdose of anesthesia, and the eyes were enucleated and fixed in 4% paraformaldehyde (0.01 M, pH 7.4). For human fetuses, the eyes were enucleated and fixed in 2% paraformaldehyde (0.01 M, pH 7.4) (Hendrickson et al., 2008) . The eye cups were immersed in a graded series of sucrose solutions overnight,
Journal of Cell Science Accepted manuscript
embedded in an optimal cutting temperature compound, and sectioned on a cryostat (Leica CM190, Wetzlar, Germany). Frozen tissues sections were cut as 10m thick transverse sections.
Immunocytochemistry was performed using our previously described methods (Duan et al., 2013) . Briefly, the cells or slides were fixed and permeabilized, then blocked in 10% serum for 30 min. The cells were incubated with primary antibody at 37°C for 2 hours, washed with PBS, incubated with secondary antibody, washed with PBS, incubated with 6-diamidino-2-phenylindole (DAPI) for 10 min at room temperature, and washed with PBS.
The following primary antibodies were used: anti-C-kit antibody ( 
Fluorescence-activated cell sorting
The cells were digested with HyQtase for 5 min, followed by the addition of 3 ml of wash buffer (Biolegend) and centrifugation at 400×g for 5 min at 4°C. Then, the cells were 
Journal of Cell Science Accepted manuscript
Expansion of C-kit + cells
Sorted cells were plated at a density of 3-5×10 3 /cm 2 and cultured in proliferation medium DMEM/F12 supplemented with 20% FBS, 20 ng/ml bFGF, 20 ng/ml EGF, and 10 ng/ml EGF for 3 days. Then, the medium was changed and the FBS concentration was decreased to 10%.
The medium was changed every 3 days, and the cells were passaged until they reached 80% confluency (every 3-4 days) at a constant seeding density of 10,000 to 13,000 cells/cm 2 .
Cell differentiation
Analysis of cell differentiation was performed using previously described methods (Coles, 2004; Li et al., 2013) . Briefly, 5×10 3 cells/well of three passages of RPCs were seeded into 24-well plates on glass coverslips pre-coated with 0.015 mg/ml poly-lysine (Sigma) in glia differentiation medium. For photoreceptor and other retinal cell differentiation, 5×10 3 cells
were seeded into 24-well plates on coverslips pre-coated with poly-L-lysine in photoreceptor differentiation medium; the differentiation medium was changed every 4 days.
The glia differentiation medium consisted of DMEM/F12 (Hyclone) supplemented with 10 ng/ml bFGF (PeproTech), 1× P-S (GIBCO), 1% FBS (GIBCO), and 2μg/ml heparin (Sigma).
The photoreceptor differentiation medium consisted of DMEM/F12 (Hyclone) supplemented with 10 ng/ml bFGF (PeproTech), 1× penicillin-streptomycin (GIBCO), 500 nM retinoic acid (Sigma), and 2% B27 (GIBCO).
Cell proliferation curve
The cell proliferation assay was performed as previously described. Briefly, three passages of RPCs were seeded into 15 wells of a 24-well plate at a density of 10,000 cells/cm 2 . The cell number was counted in 3 wells at 1, 3, 5, 7, and 9 days; the experiment was repeated 3 times.
The average number of cells was used to generate the cell proliferation curve.
Animal feeding
The animals were treated as described under a protocol approved by the Institutional Animal from 1 day before transplantation until they were sacrificed (Lu et al., 2010) .
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Cell transplantation
Royal College of Surgeons (RCS) rats (males and females, 2-3 weeks old) were used for cell transplantation. Rats with congenital microphthalmia, dysplasia of extremities, or congenital cataracts were excluded from the study.
The RCS rats were randomly divided into two groups: the cell grafted group (n=9), in which the rats received a subretinal injection of 3l of a C-kit + /SSEA4 -cell suspension (cell concentration, 2×10 5 cells/l) and the PBS group (n=9), in which the rats received a subretinal injection of 3l of HBSS. In both groups, the right eyes (OD) received cell transplants (cell grafted group) or HBSS (group), while the left eyes (OS) were untreated. The left eyes of the cell grafted group served as the untreated group.
Transplantation methods were performed as previously described (Tian et al., 2011) . All rats were anesthetized with a single intra-peritoneal injection of 4% chloral hydrate (0.8 ml/100 g body weight). The pupils were dilated with 1% tropicamide. A Hamilton syringe (29 gauge;
Hamilton, Reno, NV, USA) containing the DiI (Invitrogen, Grand Island, New York, USA)-labeled cell suspension was injected into the subretinal space.
Electroretinogram
Electroretinogram (ERG) techniques used performed as previously described (Tian et al., 2011 ). The animals were tested at 4 weeks, 8 weeks, and 12 weeks. All rats were dark-adapted overnight. The anesthesia method used was described in the Cell Transplantation section. A 
Analysis of the thickness of the outer nuclear layer
Three areas of retinal ONL thickness were examined in the transplanted area (but not in the area that contained the layers of transplanted cells) in the treated and untreated groups and the sham-surgery group. The thickness of the ONL was evaluated in DAPI-stained sections in three areas along the grafted half of the retina.The ONL thickness was measured using
Image-Pro Express software.
Cell counts and analysis
The number of DiI and Recoverin double-positive cells in each image was counted at 3 locations in three areas along the grafted half of the retina from the retinal margin to the posterior pole from 3 rats for statistical analysis. Every fifth section was counted (50 µm) to avoid counting the same cell in more than one section; the cells were counted at a ×400 magnification (Wan et al., 2007; Xu et al., 2013) .
Statistical analysis
Statistical analyses were performed using SPSS for Windows Version 13.0. Data are described as mean ± standard error. Statistical comparisons were made using either Student's two-tailed t-test or analysis of variance. Differences were considered to be statistically significant at P< 0.05.
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